| 1. |
Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from
human adenovirus type 5. J. Gen. Virol.
36, 59–74.
|
| |
| 2. |
Weinberg, D. H. and Ketner, G. (1983) A cell line that supports the growth of a defective early region 4 deletion mutant of
human adenovirus type 2. Proc. Natl. Acad. Sci. USA
80, 5383–5386.
|
| |
| 3. |
Brough, D. E., Lizonova, A., Hsu, C., Kulesa, V. A., and Koveski, I. (1996) A gene transfer vector-cell line system for complete
functional complementation of adenovirus early regions E1 and E4. J. Virol.
70, 6497–6501.
|
| |
| 4. |
Krougliak, V. and Graham, F. L. (1995) Development of cell lines capable of complementing E1, E4, and protein IX defective
adenovirus type 5 mutants. Hum. Gene Ther.
6, 1575–1586.
|
| |
| 5. |
Wang, Q., Jia, X. C., and Finer, M. H. (1995) A packaging cell line for propagation of recombinant adenovirus vectors containing
two lethal gene-region deletions. Gene Ther.
2, 775–783.
|
| |
| 6. |
Yeh, P., Dedieu, J. F., Orsini, C., Vigne, E., Denefle, P., and Perricaudet, M. (1996) Efficient dual transcomplementation
of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol.
70, 559–565.
|
| |
| 7. |
Brough, D. E., Cleghon, V., and Klessig, D. F. (1992) Construction, characterization, and utilization of cell lines which
inducibly express the adenovirus DNA-binding protein. Virology
190, 624–634.
|
| |
| 8. |
Amalfitano, A., Begy, C. R., and Chamberlain, J. S. (1996) Improved adenovirus packaging cell lines to support the growth
of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. USA
93, 3352–3356.
|
| |
| 9. |
Schaack, J., Guo, X., Ho, W. Y., Karlok, M., Chen, C., and Ornelles, D. (1995) Adenovirus type 5 precursor terminal protein-expressing
293 and HeLa cell lines. J. Virol.
69, 4079–4085.
|
| |
| 10. |
Oualikene, W., Lamoureux, L., Weber, J. M., and Massie, B. (2000) Protease-deleted adenovirus vectors and complementing cell
lines: potential applications of single-round replication mutants for vaccination and gene therapy. Hum. Gene Ther.
11, 1341–1353.
|
| |
| 11. |
Zhang, W. and Imperiale, M. J. (2003) Requirement of the adenovirus IVa2 protein for virus assembly. J. Virol.
77, 3586–3594.
|
| |
| 12. |
Challberg, S. S. and Ketner, G. (1981) Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying
mutations near the right end of the viral genome. Virology
114, 196–209.
|
| |
| 13. |
Kochanek, S. (1999) High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther.
10, 2451–2459.
|
| |
| 14. |
Cao, H., Koehler, D. R., and Hu, J. (2004) Adenoviral vectors for gene replacement therapy. Viral Immunol.
17, 327–333.
|
| |
| 15. |
Pastore, L., Morral, N., Zhou, H., Garcia, R., Parks, R. J., Kochanek, S., Graham, F. L., Lee, B., and Beaudet, A. L. (1999)
Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum. Gene Ther.
10, 1773–1781.
|
| |
| 16. |
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., and Caskey, C. T. (1996) A new adenoviral vector: Replacement
of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and betagalactosidase.
Proc. Natl. Acad. Sci. USA
93, 5731–5736.
|
| |
| 17. |
Fisher, K. J., Choi, H., Burda, J., Chen, S. J., and Wilson, J. M. (1996) Recombinant adenovirus deleted of all viral genes
for gene therapy of cystic fibrosis. Virology
217, 11–22.
|
| |
| 18. |
Mitani, K., Graham, F. L., Caskey, C. T., and Kochanek, S. (1995) Rescue, propagation, and partial purification of a helper
virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA
92, 3854–3858.
|
| |
| 19. |
Falgout, B. and Ketner, G. (1987) Adenovirus early region 4 is required for efficient virus particle assembly. J. Virol.
61, 3759–3768.
|
| |
Loading...